Hepatoma with cardiac metastasis: An advanced cancer requiring advanced treatment

Table 1 Characteristics of the eight hepatoma patients with cardiac metastatsis

Number	1	2	3	4	5	6	7	8
Age, yr	54	40	53	40	50	41	70	59
Gender	Male	Male	Female	Male	Male	Male	Male	Female
Symptoms	No	No	HF, PE	HF	No	No	No	No
HBV/HCV	+/-	-/+	+/-	-/-	NA/NA	NA/NA	NA/NA	NA/NA
AFP, ng/dL	< 100	< 100	< 100	> 100	NA	NA	NA	NA
TACE	No	No	3	No	11	No	No	No
Location	RA, Lung	RA, RV, IVC	RA	RA, IVC, Scalp	LA, RA	RA	RA	RA
DT, mo	NA	NA	< 3	< 3	< 3	NA	NA	NA
ST, mo	NA	3	> 30	3	> 3	1	NA	NA
Hemorrhage (%)	5	0	0	NA	60	NA	5	5
Necrosis (%)	90	5	50	NA	20	NA	20	10

AFP: alpha-fetal protein; DT: estimated hepatoma doubling time; HB/HCV: hepatitis B/hepatitis C virus; HF: heart failure; IVC: inferior vena cava; NA: not available; RA: right atrium; RV: right ventricle; PE: pulmonary embolism; S: scalp; ST: survival time; TACE: transcatheter arterial chemoembolization.